{
    "doi": "https://doi.org/10.1182/blood.V124.21.422.422",
    "article_title": "Pre-Transplant C-Reactive Protein (CRP), Ferritin and Albumin As Biomarkers to Predict Transplant Related Mortality (TRM) after Allogeneic Hematopoietic Cell Transplant (HCT) ",
    "article_date": "December 6, 2014",
    "session_type": "721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Personalizing Transplant Outcomes",
    "abstract_text": "HCT entails substantial TRM justifying continued efforts to better risk stratify patients. Single institutional studies have suggested several clinically available biomarkers of CRP, ferritin and albumin influence TRM if not overall survival (OS). We sought to confirm the independent prognostic value of these biomarkers in a large multi-institutional cohort. The study population consisted of 784 adults with AML in remission (80%) or MDS (20%) undergoing unrelated donor HCT between 2008 and 2010 and available cryopreserved samples through the Center for International Blood and Marrow Transplant Research (CIBMTR) repository. CRP and ferritin were centrally quantified by ELISA from cryopreserved plasma whereas albumin levels obtained from center reported data. Correlation studies for biomarkers required log transformation of CRP and ferritin to produce a normal distribution. Multivariate models were fitted separately for each biomarker applying protocol specified thresholds generated from the literature of CRP > 10 mg/L, ferritin > 2500 ng/mL, albumin < 3.5 g/dL on TRM. Further analysis explored optimal cutpoints for this cohort for all significant clinical variables for TRM. HCT characteristics included a median age of 50 (range 18-78) years, HCT-CI (co-morbidity index) 3 or more in 35%, single allele/antigen mismatch (7/8) in 23%, PB as stem cell source in 83%, and myeloablative conditioning in 72%. Biomarker data were available in 783, 781 and 695 cases for CRP, ferritin and albumin respectively. The median values and ranges for each biomarker were as follows: 5.0 mg/L (0.3 - 316) for CRP, 1148 ng/mL (51 \u2013 14,298) for ferritin and 3.6 g/dL (0.6-5.3) for albumin. Log transformed CRP and ferritin showed a modest correlation (r=0.35, P 3.67 (HR=1.75, P=0.001); albumin < 3.4 (HR 1.70, P 3.67)+0.18330*ln(Ferritin)+0.44730*I(albumin<3.4), where \u201cI\u201d is an indicator function and represent 1 or 0 depending on the presence of the abnormal biomarker level in parenthesis. The risk score included adjustment for HCT-CI. The biomarkers did not influence the incidence of relapse or graft-versus-host disease with any of these models. Elevated CRP and ferritin and decreased albumin prior to HCT were associated with impaired transplant survival, primarily through higher TRM. Integration of a biomarker panel in clinical practice once validated can enhance risk-stratification, improve adjustment for comparative studies and point towards the design of biomarker driven trials. Abstract 422. Table: Multivariate analysis of TRM and OS for biomarkers, and biomarker panel risk score*  . Abnormal, N (%) . Transplant related mortality . Overall Survival . Biomarker . HR . 95% CI . P . HR . 95% CI . P . Protocol defined         CRP >10 mg/L 184 (24) 1.52 1.11 \u2013 2.07 0.008 1.22 0.98 \u2013 1.53 0.072 Ferritin >2500 ng/mL 93 (12) 1.26 0.84 \u2013 1.88 0.27 1.15 0.86 \u2013 1.54 0.35 Albumin < 3.5 g/dL 290 (42) 1.48 1.10 \u2013 2.0 0.010 1.39 1.13 \u2013 1.72 0.002 Optimal threshold, combined model **         CRP >3.67 mg/L 497 (64) 1.56 1.11 \u2013 2.19 0.010 1.24 1.00 \u2013 1.55 0.054 Log(Ferritin), linear n/a 1.20 0.99 \u2013 1.46 0.07 1.20 1.04 \u2013 1.38 0.010 <3.4 g/dL 203 (29.5) 1.58 1.16 \u2013 2.15 0.004 1.37 1.10 \u2013 1.72 0.005 Biomarker Score **  N       Low (<1.5) 200 1.0 - - 1.0   Intermediate (1.5-2.0) 331 1.66 1.10-2.49 0.015 1.38 1.06-1.80 0.017 High (>2.0) 159 2.72 1.77-4.19 <0.001 2.01 1.51-2.70 <0.001 . Abnormal, N (%) . Transplant related mortality . Overall Survival . Biomarker . HR . 95% CI . P . HR . 95% CI . P . Protocol defined         CRP >10 mg/L 184 (24) 1.52 1.11 \u2013 2.07 0.008 1.22 0.98 \u2013 1.53 0.072 Ferritin >2500 ng/mL 93 (12) 1.26 0.84 \u2013 1.88 0.27 1.15 0.86 \u2013 1.54 0.35 Albumin < 3.5 g/dL 290 (42) 1.48 1.10 \u2013 2.0 0.010 1.39 1.13 \u2013 1.72 0.002 Optimal threshold, combined model **         CRP >3.67 mg/L 497 (64) 1.56 1.11 \u2013 2.19 0.010 1.24 1.00 \u2013 1.55 0.054 Log(Ferritin), linear n/a 1.20 0.99 \u2013 1.46 0.07 1.20 1.04 \u2013 1.38 0.010 <3.4 g/dL 203 (29.5) 1.58 1.16 \u2013 2.15 0.004 1.37 1.10 \u2013 1.72 0.005 Biomarker Score **  N       Low (<1.5) 200 1.0 - - 1.0   Intermediate (1.5-2.0) 331 1.66 1.10-2.49 0.015 1.38 1.06-1.80 0.017 High (>2.0) 159 2.72 1.77-4.19 <0.001 2.01 1.51-2.70 <0.001 * biomarkers adjusted for significant covariates of BMI, disease, mismatch, and CMV serostatus and stratified on conditioning regimen ** combined model includes all biomarkers and HCT-CI View Large Disclosures No relevant conflicts of interest to declare.",
    "topics": [
        "albumins",
        "allogeneic hematopoietic stem cell transplant",
        "biological markers",
        "c-reactive protein",
        "ferritin",
        "transplantation",
        "cryopreservation",
        "antigens",
        "c-reactive protein, increased",
        "disease remission"
    ],
    "author_names": [
        "Andrew S. Artz, MD MS",
        "Brent R. Logan, PhD",
        "Xiaochun Zhu, MS",
        "G\u00f6rg\u00fcn Akpek, MD MHS",
        "Rodrigo Martino, MD PhD",
        "Vikas Gupta, MD FRCP, FRCPath",
        "Hillard M. Lazarus, MD",
        "Mark R. Litzow, MD",
        "Alison Wakoff Loren, MD MS",
        "Navneet S. Majhail, MD MS",
        "Richard T. Maziarz, MD",
        "Philip L. McCarthy, MD",
        "Uday R. Popat, MD",
        "Wael Saber, MD MS",
        "Stephen R. Spellman, MBS",
        "Olle Ringd\u00e9n, MDPhD",
        "Kenneth R. Cooke, MD",
        "Marcelo C. Pasquini, MD MS"
    ],
    "author_dict_list": [
        {
            "author_name": "Andrew S. Artz, MD MS",
            "author_affiliations": [
                "University of Chicago Medical Center, Chicago, IL "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Brent R. Logan, PhD",
            "author_affiliations": [
                "Medical College of Wisconsin, Milwaukee, WI "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Xiaochun Zhu, MS",
            "author_affiliations": [
                "Medical College of Wisconsin, Milwaukee, WI "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "G\u00f6rg\u00fcn Akpek, MD MHS",
            "author_affiliations": [
                "Section of Hematology Oncology, Gilbert, AZ "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Rodrigo Martino, MD PhD",
            "author_affiliations": [
                "Hospital de la Santa Creu i Sant Pau, Barcelona, Spain "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Vikas Gupta, MD FRCP, FRCPath",
            "author_affiliations": [
                "Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Hillard M. Lazarus, MD",
            "author_affiliations": [
                "University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mark R. Litzow, MD",
            "author_affiliations": [
                "Mayo Clinic, Rochester, MN "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alison Wakoff Loren, MD MS",
            "author_affiliations": [
                "Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Navneet S. Majhail, MD MS",
            "author_affiliations": [
                "Cleveland Clinic, Cleveland, OH "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Richard T. Maziarz, MD",
            "author_affiliations": [
                "Oregon Health & Science University, Portland, OR "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Philip L. McCarthy, MD",
            "author_affiliations": [
                "Roswell Park Cancer Institute, Buffalo, NY "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Uday R. Popat, MD",
            "author_affiliations": [
                "The University of Texas MD Anderson Cancer Center, Houston, TX "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Wael Saber, MD MS",
            "author_affiliations": [
                "Medical College of Wisconsin, Milwaukee, WI "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stephen R. Spellman, MBS",
            "author_affiliations": [
                "Center for International Blood and Marrow Transplant Research, Minneapolis, MN "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Olle Ringd\u00e9n, MDPhD",
            "author_affiliations": [
                "Karolinska University Hospital Huddinge, Stockholm, Sweden "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Kenneth R. Cooke, MD",
            "author_affiliations": [
                "Johns Hopkins University, Baltimore, MD "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marcelo C. Pasquini, MD MS",
            "author_affiliations": [
                "Medical College of Wisconsin, Milwaukee, WI"
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-29T06:48:43",
    "is_scraped": "1"
}